Literature DB >> 12846804

Transcriptional regulatory cascades controlling plasma cell differentiation.

Kuo-I Lin1, Chainarong Tunyaplin, Kathryn Calame.   

Abstract

Plasma cells are the terminally differentiated effector cells of the B lymphocyte lineage. Recently, studies using genetically altered mice and analyses of global gene expression programs have significantly expanded our understanding of the molecular mechanisms regulating plasmacytic differentiation. Specific molecular components of a multistep cascade of transcriptional regulators have been identified. Furthermore, two transcriptional regulators, X box binding protein-1 (XBP-1) and B lymphocyte induced maturation protein-1 (Blimp-1), have been shown to be necessary for plasmacytic differentiation. In addition to providing a mechanistic basis for the induction of genes necessary for immunoglobulin secretion, cessation of cell cycle and other phenotypic changes characteristic of terminally differentiated plasma cells, these studies have led to the important concept that plasmacytic differentiation involves repression of regulators, such as Bcl-6 and Pax5, that are necessary to maintain the earlier developmental phenotype of activated, germinal center B cells. This review describes our current understanding of the transcriptional cascades regulating terminal differentiation of B cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12846804     DOI: 10.1034/j.1600-065x.2003.00040.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  29 in total

1.  Early preplasma cells define a tolerance checkpoint for autoreactive B cells.

Authors:  Donna A Culton; Brian P O'Conner; Kara L Conway; Ramiro Diz; Jennifer Rutan; Barbara J Vilen; Stephen H Clarke
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

2.  Transcription factor MIST1 in terminal differentiation of mouse and human plasma cells.

Authors:  Benjamin J Capoccia; Jochen K M Lennerz; Andrew J Bredemeyer; Jeffery M Klco; John L Frater; Jason C Mills
Journal:  Physiol Genomics       Date:  2010-11-23       Impact factor: 3.107

3.  The in vivo function of a noncanonical TRAF2-binding domain in the C-terminus of CD40 in driving B-cell growth and differentiation.

Authors:  Li-Fan Lu; Cory L Ahonen; Evan F Lind; Vanitha S Raman; W James Cook; Ling-Li Lin; Randolph J Noelle
Journal:  Blood       Date:  2007-03-14       Impact factor: 22.113

4.  A Drosophila model of the rhabdomyosarcoma initiator PAX7-FKHR.

Authors:  Rene L Galindo; Jay A Allport; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

5.  Fas apoptosis inhibitory molecule enhances CD40 signaling in B cells and augments the plasma cell compartment.

Authors:  Hiroaki Kaku; Thomas L Rothstein
Journal:  J Immunol       Date:  2009-07-10       Impact factor: 5.422

6.  Plasma cell maturity as a predictor of prognosis in multiple myeloma.

Authors:  Noriyoshi Iriyama; Katsuhiro Miura; Yoshihiro Hatta; Yoshihito Uchino; Daisuke Kurita; Hiromichi Takahashi; Hitomi Sakagami; Masashi Sakagami; Yujin Kobayashi; Masaru Nakagawa; Shimon Ohtake; Yoshikazu Iizuka; Masami Takei
Journal:  Med Oncol       Date:  2016-07-06       Impact factor: 3.064

7.  A bistable switch underlying B-cell differentiation and its disruption by the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  Sudin Bhattacharya; Rory B Conolly; Norbert E Kaminski; Russell S Thomas; Melvin E Andersen; Qiang Zhang
Journal:  Toxicol Sci       Date:  2010-02-01       Impact factor: 4.849

8.  A novel subset of memory B cells is enriched in autoreactivity and correlates with adverse outcomes in SLE.

Authors:  Matilda W Nicholas; Mary Anne Dooley; Susan L Hogan; Jennifer Anolik; John Looney; Ingnacio Sanz; Stephen H Clarke
Journal:  Clin Immunol       Date:  2008-02       Impact factor: 3.969

9.  Mesenchymal stem cells suppress B-cell terminal differentiation.

Authors:  Sadaki Asari; Shin Itakura; Kevin Ferreri; Chih-Pin Liu; Yoshikazu Kuroda; Fouad Kandeel; Yoko Mullen
Journal:  Exp Hematol       Date:  2009-05       Impact factor: 3.084

10.  BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.

Authors:  Samir Parekh; Jose M Polo; Rita Shaknovich; Przemyslaw Juszczynski; Paola Lev; Stella M Ranuncolo; Yingnan Yin; Ulf Klein; Giorgio Cattoretti; Riccardo Dalla Favera; Margaret A Shipp; Ari Melnick
Journal:  Blood       Date:  2007-06-01       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.